Torthaí cuardaigh - Gil Redelman‐Sidi
- 1 - 13 toradh as 13 á dtaispeáint
-
1
Could BCG be used to protect against COVID-19? de réir Gil Redelman‐Sidi
Foilsithe / Cruthaithe 2020Revisão -
2
BCG in Bladder Cancer Immunotherapy de réir Song Jiang, Gil Redelman‐Sidi
Foilsithe / Cruthaithe 2022Revisão -
3
Rapidly Growing Mycobacteria Infection in Patients with Cancer de réir Gil Redelman‐Sidi, Kent A. Sepkowitz
Foilsithe / Cruthaithe 2010Artigo -
4
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy de réir Tommaso Morelli, Kohei Fujita, Gil Redelman‐Sidi, Paul Elkington
Foilsithe / Cruthaithe 2021Revisão -
5
Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells de réir Gil Redelman‐Sidi, Gopa Iyer, David B. Solit, Michael S. Glickman
Foilsithe / Cruthaithe 2013Artigo -
6
Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways de réir Richa Gupta, Daniel Barkan, Gil Redelman‐Sidi, Stewart Shuman, Michael S. Glickman
Foilsithe / Cruthaithe 2010Artigo -
7
-
8
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune ch... de réir Gil Redelman‐Sidi, Olivier Michielin, Carlos Cervera, Camillo Ribi, José María Aguado, Mario Fernández‐Ruiz, Oriol Manuel
Foilsithe / Cruthaithe 2018Revisão -
9
Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer de réir Tilly Varughese, Ying Taur, Nina Cohen, M. Lia Palomba, Susan K. Seo, Tobias M. Hohl, Gil Redelman‐Sidi
Foilsithe / Cruthaithe 2018Artigo -
10
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma de réir María del Carmen López Castillo, Fabián Andrés Rosas Romero, Esther Argüello, Chrisann Kyi, Michael A. Postow, Gil Redelman‐Sidi
Foilsithe / Cruthaithe 2016Artigo -
11
The Canonical Wnt Pathway Drives Macropinocytosis in Cancer de réir Gil Redelman‐Sidi, Anna Binyamin, Isabella Gaeta, Wilhelm Palm, Craig B. Thompson, Paul B. Romesser, Scott W. Lowe, Mukta Bagul, John G. Doench, David E. Root, Michael S. Glickman
Foilsithe / Cruthaithe 2018Artigo -
12
Determinants of Severity in Cancer Patients with COVID-19 Illness de réir Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, C. Ortiz, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj
Foilsithe / Cruthaithe 2020Pré-impressão -
13
Determinants of COVID-19 disease severity in patients with cancer de réir Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, Cesar J. Figueroa, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj
Foilsithe / Cruthaithe 2020Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Cancer
Internal medicine
Immunology
Biology
Cancer research
Immune system
Immunotherapy
Cancer immunotherapy
Cell biology
Coronavirus disease 2019 (COVID-19)
Disease
Genetics
Infectious disease (medical specialty)
Pathology
Receptor
Tuberculosis
Bladder cancer
Cancer cell
Carcinogenesis
Cell
Endocytosis
Environmental health
Immunity
Intensive care medicine
Lung cancer
Mycobacterium tuberculosis
Oncology
Pinocytosis
Population